David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Interface
TILE
$2.24B
| $2.84M | ﹤0.01% |
224,885
-134,898
| -37% | -$1.38M |
|
|
PGRE
2252
DELISTED
Paramount Group
PGRE
| $2.84M | ﹤0.01% |
548,501
+203,273
| +59% | +$965K |
|
2253
CALL
Signet Jewelers
SIG
$3.25B
| $2.83M | ﹤0.01% |
26,400
+16,400
| +164% | +$1.34M |
|
2254
Regenxbio
RGNX
$619M
| $2.83M | ﹤0.01% |
157,640
+113,012
| +253% | +$1.99M |
|
2255
Jabil
JBL
$32.6B
| $2.82M | ﹤0.01% |
22,169
-19,789
| -47% | -$2.52M |
|
2256
HealthStream
HSTM
$841M
| $2.82M | ﹤0.01% |
104,206
-6,744
| -6% | -$168K |
|
2257
Tidewater
TDW
$4.42B
| $2.82M | ﹤0.01% |
39,040
-132,530
| -77% | -$8.58M |
|
|
CNR
2258
CALL
Core Natural Resources Inc
CNR
$4.87B
| $2.81M | ﹤0.01% |
28,000
| – | – |
|
|
DFS
2259
PUT
DELISTED
Discover Financial Services
DFS
| $2.81M | ﹤0.01% |
25,000
-38,900
| -61% | -$3.6M |
|
2260
Domo
DOMO
$178M
| $2.8M | ﹤0.01% |
272,462
-80,779
| -23% | -$746K |
|
2261
3M
MMM
$92.8B
| $2.8M | ﹤0.01% |
30,648
-922,801
| -97% | -$74.1M |
|
|
OLO
2262
DELISTED
Olo Inc
OLO
| $2.8M | ﹤0.01% |
489,566
-305,182
| -38% | -$1.68M |
|
2263
Restaurant Brands International
QSR
$27.6B
| $2.79M | ﹤0.01% |
35,760
-49,196
| -58% | -$3.42M |
|
|
TCS
2264
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $2.79M | ﹤0.01% |
81,628
+1,528
| +2% | +$46.3K |
|
|
PPLI
2265
PUT
People Inc
PPLI
$2.92B
| $2.79M | ﹤0.01% |
64,851
+853
| +1% | +$33.4K |
|
2266
CALL
HP
HPQ
$27.9B
| $2.78M | ﹤0.01% |
92,400
+75,800
| +457% | +$2.12M |
|
|
GTLS.PRB
2267
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
| $2.78M | ﹤0.01% |
+50,000
| New | +$2.77M |
|
2268
Codexis
CDXS
$181M
| $2.78M | ﹤0.01% |
911,138
-689,746
| -43% | -$1.48M |
|
2269
Upbound Group
UPBD
$1.13B
| $2.78M | ﹤0.01% |
81,731
-45,230
| -36% | -$1.35M |
|
|
AVDL
2270
DELISTED
Avadel Pharmaceuticals
AVDL
| $2.78M | ﹤0.01% |
196,554
-352,816
| -64% | -$4.14M |
|
2271
Lindsay Corp
LNN
$1.16B
| $2.77M | ﹤0.01% |
21,448
+8,461
| +65% | +$1.04M |
|
2272
PUT
Tanger
SKT
$4.37B
| $2.77M | ﹤0.01% |
+99,900
| New | +$2.49M |
|
2273
CALL
Alaska Air
ALK
$4.8B
| $2.77M | ﹤0.01% |
70,800
+46,000
| +185% | +$1.64M |
|
2274
CALL
Newmont
NEM
$139B
| $2.76M | ﹤0.01% |
66,600
-18,800
| -22% | -$726K |
|
2275
Tandem Diabetes Care
TNDM
$1.49B
| $2.76M | ﹤0.01% |
93,140
-157,804
| -63% | -$3.27M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.